His primary areas of study are Internal medicine, Endocrinology, Psychiatry, Placebo and Clinical psychology. His study on Endocrinology is mostly dedicated to connecting different topics, such as Serotonin. His biological study spans a wide range of topics, including Agonist and Central nervous system.
His work in Psychiatry covers topics such as Premenstrual dysphoric disorder which are related to areas like Mood disorders. His Placebo research is multidisciplinary, incorporating elements of Citalopram, Anesthesia and Psychopharmacology. Elias Eriksson combines subjects such as Developmental psychology, Aggression and HTR3B with his study of Clinical psychology.
Elias Eriksson mostly deals with Internal medicine, Endocrinology, Psychiatry, Serotonin and Pharmacology. His work focuses on many connections between Internal medicine and other disciplines, such as Placebo, that overlap with his field of interest in Anesthesia. His Dopamine study, which is part of a larger body of work in Endocrinology, is frequently linked to Chemistry, bridging the gap between disciplines.
His Psychiatry research is multidisciplinary, relying on both Clinical psychology and Premenstrual dysphoric disorder. Elias Eriksson focuses mostly in the field of Reuptake inhibitor, narrowing it down to topics relating to Serotonin reuptake inhibitor and, in certain cases, Irritability. The concepts of his Panic disorder study are interwoven with issues in Imipramine and Polymorphism.
Elias Eriksson spends much of his time researching Internal medicine, Psychiatry, Depression, Serotonin and Endocrinology. He studies Reuptake inhibitor which is a part of Internal medicine. His work on Cognition as part of general Psychiatry research is frequently linked to Injury prevention, thereby connecting diverse disciplines of science.
His work carried out in the field of Depression brings together such families of science as Severity of illness and Treatment response. His Serotonin research includes themes of Aggression and Anxiety. His Endocrinology research incorporates themes from Tryptophan hydroxylase and Polymorphism.
Elias Eriksson focuses on Internal medicine, Citalopram, Psychiatry, Genetics and Placebo. His work deals with themes such as Endocrinology, Clinical psychology and Anxiety, which intersect with Internal medicine. His study in Citalopram is interdisciplinary in nature, drawing from both Pharmacology, Paroxetine, Serotonin Uptake Inhibitors and Sertraline.
Elias Eriksson has researched Psychiatry in several fields, including Clinical study design, Serotonin reuptake and Premenstrual dysphoric disorder. His Genetics research includes elements of Schizophrenia and Cognition. In Placebo, Elias Eriksson works on issues like Depression, which are connected to Rating scale, Fluoxetine, Treatment response and Treatment efficacy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genetic variation in the vasopressin receptor 1a gene (AVPR1A) associates with pair-bonding behavior in humans
Hasse Walum;Lars Westberg;Susanne Henningsson;Jenae M. Neiderhiser.
Proceedings of the National Academy of Sciences of the United States of America (2008)
The Serotonin Reuptake Inhibitor Paroxetin Is Superior to the Noradrenaline Reuptake Inhibitor Maprotiline in the Treatment of Premenstrual Syndrome
Elias Eriksson;Marina A Hedberg;Björn Andersch;Charlotta Sundblad.
Premenstrual Dysphoric Disorder: Evidence for a New Category for DSM-5
C. Neill Epperson;Meir Steiner;S. Ann Hartlage;Elias Eriksson.
American Journal of Psychiatry (2012)
Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor β Gene Are Associated with Androgen Levels in Women1
Lars Westberg;Fariba Baghaei;Roland Rosmond;Monika Hellstrand.
The Journal of Clinical Endocrinology and Metabolism (2001)
A Link between Serotonin-Related Gene Polymorphisms, Amygdala Activity, and Placebo-Induced Relief from Social Anxiety
Tomas Furmark;Lieuwe Appel;Susanne Henningsson;Fredrik Åhs.
The Journal of Neuroscience (2008)
Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders : the ISPMD Montreal consensus
Patrick Michael Shaughn O’Brien;Torbjorn Bäckström;Candace Brown;Lorraine Dennerstein.
Archives of Womens Mental Health (2011)
Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies
Uriel Halbreich;Torbjörn Bäckström;Elias Eriksson;Shawn O'brien.
Gynecological Endocrinology (2007)
Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?
Ida Wikander;Charlotta Sundblad;Bjorn Andersch;Inger Dagnell.
Journal of Clinical Psychopharmacology (1998)
Prenatal cytokine exposure results in obesity and gender-specific programming
Jovanna Dahlgren;Cecilia Nilsson;Eva Jennische;Hoi-Por Ho.
American Journal of Physiology-endocrinology and Metabolism (2001)
Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors.
Mikael Landen;Elias Eriksson;Hans Agren;Tom Fahlen.
Journal of Clinical Psychopharmacology (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: